SE435839B - Analogiforfarande for framstellning av ergopeptidalkaloidderivat - Google Patents

Analogiforfarande for framstellning av ergopeptidalkaloidderivat

Info

Publication number
SE435839B
SE435839B SE7709645A SE7709645A SE435839B SE 435839 B SE435839 B SE 435839B SE 7709645 A SE7709645 A SE 7709645A SE 7709645 A SE7709645 A SE 7709645A SE 435839 B SE435839 B SE 435839B
Authority
SE
Sweden
Prior art keywords
ergopeptidalcaloid
derivatives
preparation
analogy procedure
analogy
Prior art date
Application number
SE7709645A
Other languages
English (en)
Swedish (sv)
Other versions
SE7709645L (sv
Inventor
P Stutz
P Stadler
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1128776A external-priority patent/CH623592A5/de
Priority claimed from CH1128676A external-priority patent/CH623591A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7709645L publication Critical patent/SE7709645L/xx
Publication of SE435839B publication Critical patent/SE435839B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7709645A 1976-09-06 1977-08-29 Analogiforfarande for framstellning av ergopeptidalkaloidderivat SE435839B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1128776A CH623592A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives
CH1128676A CH623591A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives

Publications (2)

Publication Number Publication Date
SE7709645L SE7709645L (sv) 1978-03-07
SE435839B true SE435839B (sv) 1984-10-22

Family

ID=25708069

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7709645A SE435839B (sv) 1976-09-06 1977-08-29 Analogiforfarande for framstellning av ergopeptidalkaloidderivat

Country Status (15)

Country Link
JP (1) JPS5331698A (da)
AU (1) AU512027B2 (da)
CA (1) CA1105007A (da)
DE (1) DE2738730A1 (da)
DK (1) DK147390C (da)
ES (1) ES462080A1 (da)
FI (1) FI64942C (da)
FR (1) FR2363571A1 (da)
GB (2) GB1590149A (da)
IE (1) IE46152B1 (da)
IL (1) IL52896A (da)
NL (1) NL7709683A (da)
NZ (1) NZ185098A (da)
PT (1) PT67003B (da)
SE (1) SE435839B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2013158449A (ru) * 2011-06-23 2015-07-27 Мэп Фармасьютикалс, Инк. Новые фторэрголиновые аналоги

Also Published As

Publication number Publication date
CA1105007A (en) 1981-07-14
ES462080A1 (es) 1978-12-01
GB1590150A (en) 1981-05-28
IL52896A0 (en) 1977-11-30
IL52896A (en) 1980-07-31
DK147390C (da) 1985-02-04
NZ185098A (en) 1980-04-28
DK382777A (da) 1978-03-07
AU512027B2 (en) 1980-09-18
PT67003A (en) 1977-10-01
GB1590149A (en) 1981-05-28
NL7709683A (nl) 1978-03-08
JPS5331698A (en) 1978-03-25
FR2363571B1 (da) 1980-04-18
DK147390B (da) 1984-07-16
DE2738730A1 (de) 1978-03-16
AU2857277A (en) 1979-03-15
IE46152L (en) 1978-03-06
FI64942C (fi) 1984-02-10
FI772557A (fi) 1978-03-07
PT67003B (en) 1979-05-14
SE7709645L (sv) 1978-03-07
IE46152B1 (en) 1983-03-09
FR2363571A1 (fr) 1978-03-31
FI64942B (fi) 1983-10-31

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO834236L (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
NO772960L (no) Fremgangsmaate til fremstilling av cefalosporinderivater
SE435510B (sv) Analogiforfarande for framstellning av 3-fluor-6-piperazinylmorfantridiner
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE7707407L (sv) Forfarande for framstellning av cefamderivat
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat